Acquired resistance to cetuximab is mediated by increased PTEN instability and leads cross-resistance to gefitinib in HCC827 NSCLC cellsSun Mi Kim, Byoung Chul Cho, Joo-Hang Kim et al.|Cancer Letters|2010Cited by 57